biote Corp. (BTMD) Financial Statements
Industry: Medicinal Chemicals & Botanical Products
In fiscal 2025, biote reported revenue of $192.2M, down 2.5% from $197.2M the year before. Net income was $27.0M (a 14.1% net margin), or $0.74 per diluted share. Operating margin was 18.5%. Operating activities generated $35.2M of cash, leaving $30.2M of free cash flow. At fiscal year end, biote held $107.6M in total assets against $158.0M in total liabilities, including $24.1M of cash and equivalents.
Open the full interactive biote financials → Quarterly statements, key ratios, valuation history and price charts.
biote Key Stats
| Share Price | $1.04 |
|---|---|
| Market Cap | $29.8M |
| P/E Ratio | 1.4 |
| Dividend Yield | 3.92% |
| Revenue YoY Growth | -2.5% |
| 52-Week Range | $1.04 – $3.19 |
| Shares Outstanding | 28.6 million (basic, 2026 Q2) |
biote Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $165.0M | $185.4M | $197.2M | $192.2M |
| Cost of Goods Sold | $0 | — | — | — | — |
| Gross Profit | $0 | — | — | — | — |
| Operating Income | -$3.3M | -$60.7M | $28.7M | $31.6M | $35.6M |
| Pre-Tax Income | $11.1M | $1.7M | -$123,000 | $1.0M | $37.6M |
| Income Tax | $0 | $388,000 | $2.7M | $970,000 | $6.0M |
| Net Income | $11.1M | -$969,000 | $3.3M | $3.2M | $27.0M |
| Diluted EPS | $0.32 | -$0.12 | $0.13 | $0.09 | $0.74 |
biote Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $48.0M | $46.4M | $44.9M | $44.2M |
| Net Income | $8.2M | $2.0M | $2.3M | -$6.6M |
| Diluted EPS | $0.22 | $0.05 | $0.06 | -$0.23 |
biote Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $130,359 | — | $89.0M | $39.3M | $24.1M |
| Current Assets | $451,618 | $101.2M | $122.3M | $68.1M | $54.7M |
| Total Assets | $318.0M | $111.6M | $155.3M | $122.4M | $107.6M |
| Current Liabilities | $2.3M | $18.8M | $22.2M | $51.5M | $45.0M |
| Total Long-Term Debt | — | $118.3M | $112.9M | $107.4M | $102.0M |
| Total Liabilities | $23.2M | $169.9M | $191.8M | $224.6M | $158.0M |
| Shareholders' Equity | -$22.6M | -$44.5M | -$29.4M | -$105.9M | -$58.5M |
biote Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$1.4M | -$9.2M | $26.9M | $45.2M | $35.2M |
| Cash From Investing | -$317.5M | -$1.8M | -$2.7M | -$18.8M | -$6.9M |
| Cash From Financing | $319.0M | $63.5M | -$14.4M | -$76.1M | -$43.6M |
| Free Cash Flow | — | -$9.5M | $26.5M | $38.8M | $30.2M |
| Dividends Paid | — | $12.9M | $8.7M | $4.7M | $1.7M |
Figures from biote's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full biote financials page for every line item.
biote Company Profile
| Ticker | BTMD |
|---|---|
| Exchange | Nasdaq |
| Industry | Medicinal Chemicals & Botanical Products |
| Headquarters | Irving, Texas |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001819253 |
Frequently Asked Questions
What was biote's revenue in fiscal 2025?
biote (BTMD) reported revenue of $192.2M for fiscal 2025.
What is biote's annual revenue history?
biote's annual revenue by fiscal year: 2021: $0; 2022: $165.0M; 2023: $185.4M; 2024: $197.2M; 2025: $192.2M.
What was biote's net income in fiscal 2025?
biote reported net income of $27.0M for fiscal 2025.
What was biote's earnings per share (EPS) in fiscal 2025?
biote's diluted EPS was $0.74 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did biote generate in fiscal 2025?
biote generated $30.2M of free cash flow in fiscal 2025.
What was biote's revenue last quarter?
In its most recent reported quarter (2026 Q2), biote reported revenue of $44.2M.
How much debt does biote have?
biote reported $102.0M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of biote are outstanding?
biote reported a weighted average of 28.6 million basic shares outstanding in 2026 Q2.
What is biote's market cap?
Based on its latest closing price, biote (BTMD) has a market capitalization of about $29.8M.
When does biote's fiscal year end?
biote's fiscal year end, as registered with the SEC, is December 31.
Where is biote headquartered?
biote lists its business address in Irving, Texas in its SEC filings.
biote Competitors & Similar Companies
See all 11 Medicinal Chemicals & Botanical Products companies →